OBJECTIVE: Type I interferon (IFN) signaling is a central pathogenic pathway in systemic lupus erythematosus (SLE), and therapeutics targeting type I IFN signaling are in development. Multiple proteins with overlapping functions play a role in IFN signaling, but the signaling events downstream of receptor engagement are unclear. This study was undertaken to investigate the roles of the type I and type II IFN signaling components IFN-α/β/ω receptor 2 (IFNAR-2), IFN regulatory factor 9 (IRF-9), and STAT-1 in a mouse model of SLE. METHODS: We used immunohistochemical staining and highly multiplexed assays to characterize pathologic changes in histology, autoantibody production, cytokine/chemokine profiles, and STAT phosphorylation in order to investigate the individual roles of IFNAR-2, IRF-9, and STAT-1 in MRL/lpr mice. RESULTS: We found that STAT-1(-/-) mice, but not IRF-9(-/-) or IFNAR-2(-/-) mice, developed interstitial nephritis characterized by infiltration with retinoic acid receptor-related orphan nuclear receptor γt-positive lymphocytes, macrophages, and eosinophils. Despite pronounced interstitial kidney disease and abnormal kidney function, STAT-1(-/-) mice had decreased proteinuria, glomerulonephritis, and autoantibody production. Phosphospecific flow cytometry revealed shunting of STAT phosphorylation from STAT-1 to STAT-3/4. CONCLUSION: We describe unique contributions of STAT-1 to pathology in different kidney compartments in a mouse model, and provide potentially novel insight into tubulointerstitial nephritis, a poorly understood complication that predicts end-stage kidney disease in SLE patients.
OBJECTIVE: Type I interferon (IFN) signaling is a central pathogenic pathway in systemic lupus erythematosus (SLE), and therapeutics targeting type I IFN signaling are in development. Multiple proteins with overlapping functions play a role in IFN signaling, but the signaling events downstream of receptor engagement are unclear. This study was undertaken to investigate the roles of the type I and type II IFN signaling components IFN-α/β/ω receptor 2 (IFNAR-2), IFN regulatory factor 9 (IRF-9), and STAT-1 in a mouse model of SLE. METHODS: We used immunohistochemical staining and highly multiplexed assays to characterize pathologic changes in histology, autoantibody production, cytokine/chemokine profiles, and STAT phosphorylation in order to investigate the individual roles of IFNAR-2, IRF-9, and STAT-1 in MRL/lprmice. RESULTS: We found that STAT-1(-/-) mice, but not IRF-9(-/-) or IFNAR-2(-/-) mice, developed interstitial nephritis characterized by infiltration with retinoic acid receptor-related orphan nuclear receptor γt-positive lymphocytes, macrophages, and eosinophils. Despite pronounced interstitial kidney disease and abnormal kidney function, STAT-1(-/-) mice had decreased proteinuria, glomerulonephritis, and autoantibody production. Phosphospecific flow cytometry revealed shunting of STAT phosphorylation from STAT-1 to STAT-3/4. CONCLUSION: We describe unique contributions of STAT-1 to pathology in different kidney compartments in a mouse model, and provide potentially novel insight into tubulointerstitial nephritis, a poorly understood complication that predicts end-stage kidney disease in SLEpatients.
Authors: John C Hall; Livia Casciola-Rosen; Alan E Berger; Efstathia K Kapsogeorgou; Chris Cheadle; Athanasios G Tzioufas; Alan N Baer; Antony Rosen Journal: Proc Natl Acad Sci U S A Date: 2012-10-08 Impact factor: 11.205
Authors: José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos Journal: J Immunol Date: 2008-12-15 Impact factor: 5.422
Authors: Roberto Baccala; Rosana Gonzalez-Quintial; Robert D Schreiber; Brian R Lawson; Dwight H Kono; Argyrios N Theofilopoulos Journal: J Immunol Date: 2012-11-21 Impact factor: 5.422
Authors: Jordan V Price; Stephanie Tangsombatvisit; Guangyu Xu; Jiangtao Yu; Dan Levy; Emily C Baechler; Or Gozani; Madoo Varma; Paul J Utz; Chih Long Liu Journal: Nat Med Date: 2012-09 Impact factor: 53.440
Authors: Bettina L Lee; Joanne E Moon; Jeffrey H Shu; Lin Yuan; Zachary R Newman; Randy Schekman; Gregory M Barton Journal: Elife Date: 2013-02-19 Impact factor: 8.140
Authors: Paul A Lyons; Eoin F McKinney; Tim F Rayner; Alexander Hatton; Hayley B Woffendin; Maria Koukoulaki; Thomas C Freeman; David R W Jayne; Afzal N Chaudhry; Kenneth G C Smith Journal: Ann Rheum Dis Date: 2009-10-07 Impact factor: 19.103
Authors: Gloria Yiu; Tue Kruse Rasmussen; Brandon L Tsai; Vivian K Diep; David J Haddon; Jennifer Tsoi; Gopika D Miller; Begoña Comin-Anduix; Bent Deleuran; Gay M Crooks; Paul J Utz Journal: Front Immunol Date: 2022-01-28 Impact factor: 7.561